title: [Statement of the German Society of Rheumatology (DGRh) reporting on the Institute's plan for biologicals in the second-line therapy for rheumatoid arthritis].
authors.affiliation: Deutsche Gesellschaft für Rheumatologie e.V. , Köpenicker Straße 48/49, 10179, Berlin, Deutschland. J.Braun@rheumazentrum-ruhrgebiet.de
authors.forename: J
authors.initials: J
authors.lastname: Braun
authors.forename: K
authors.initials: K
authors.lastname: Krüger
authors.forename: E
authors.initials: E
authors.lastname: Genth
mesh_terms: D018501:Antirheumatic Agents / Q000592:standards* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000592:standards* / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000592:standards*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products